Clearside Biomedical, Inc. (CLSD)
NASDAQ: CLSD · Real-Time Price · USD
1.020
-0.030 (-2.86%)
At close: Nov 21, 2024, 4:00 PM
1.021
+0.001 (0.11%)
After-hours: Nov 21, 2024, 5:14 PM EST
Clearside Biomedical Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 77 | 73 | 67 | 164 | 132 | 119 | |
| Market Cap Growth | 75.92% | 8.31% | -58.91% | 23.85% | 11.02% | 248.26% | |
| Enterprise Value | 106 | 86 | 46 | 140 | 120 | 108 | |
| Last Close Price | 1.05 | 1.17 | 1.12 | 2.75 | 2.74 | 2.90 | |
| PE Ratio | - | - | - | 427.82 | - | - | |
| PS Ratio | 9.60 | 8.88 | 50.80 | 5.55 | 16.78 | 54.92 | |
| PB Ratio | -2.73 | -4.59 | 6.36 | 4.32 | 15.12 | 10.70 | |
| P/TBV Ratio | - | - | 6.36 | 4.32 | 15.12 | 10.70 | |
| EV/Sales Ratio | 13.76 | 10.46 | 34.95 | 4.72 | 15.16 | 49.88 | |
| Debt / Equity Ratio | -1.44 | -2.70 | 3.32 | 0.02 | 0.23 | 0.57 | |
| Asset Turnover | 0.24 | 0.19 | 0.03 | 0.95 | 0.34 | 0.06 | |
| Quick Ratio | 4.36 | 4.27 | 8.34 | 8.71 | 1.74 | 2.07 | |
| Current Ratio | 4.49 | 4.42 | 8.54 | 9.08 | 1.82 | 2.31 | |
| Return on Equity (ROE) | - | - | -135.63% | 1.61% | -182.83% | -176.96% | |
| Return on Assets (ROA) | -48.46% | -36.40% | -40.17% | -1.26% | -48.63% | -53.43% | |
| Return on Capital (ROIC) | -69.81% | -42.57% | -44.78% | -1.59% | -79.19% | -74.04% | |
| Earnings Yield | -40.03% | -44.49% | -48.87% | 0.23% | -13.74% | -25.78% | |
| FCF Yield | -24.61% | -27.27% | -20.19% | -6.54% | -9.94% | -22.70% | |
| Buyback Yield / Dilution | -14.89% | -2.66% | -0.50% | -28.81% | -21.84% | -24.20% | |
| Total Shareholder Return | -14.89% | -2.66% | -0.50% | -28.81% | -21.84% | -24.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.